XML 467 R57.htm IDEA: XBRL DOCUMENT

Fair value measurement (Tables)

12 Months Ended

Mar. 31, 2023

Summary of comparison by class of carrying amount and fair value of the group's financial instruments

		Carrying value								Fair value
		As at March 31,				As at March 31,				As at March 31,				As at March 31,
		2022				2023				2022				2023
Financial assets
Assets carried at amortized cost
Trade and other receivables			1,934,713				3,061,209				1,934,713				3,061,209
Cash and cash equivalents			800,282				503,601				800,282				503,601
Term deposits			568,264				587,375				568,264				587,375
Other financial assets			120,385				122,312				120,385				122,312
Total			3,423,644				4,274,497				3,423,644				4,274,497

Financial liabilities
Liabilities carried at fair value
Share warrants*			-				-				-				-
Total			-				-				-				-

Liabilities carried at amortized cost
Trade and other payables			2,437,317				2,176,353				2,437,317				2,176,353
Borrowings			358,580				2,396,494				358,580				2,396,494
Other liabilities			566,901				514,562				566,901				514,562
Total			3,362,798				5,087,409				3,362,798				5,087,409

Schedule of financial instruments by fair value hierarchy

		March 31, 2022
		Level 1				Level 2				Level 3				Total
Assets for which fair value is disclosed
Term deposits			-				568,264				-				568,264
Other financial assets			-				120,385				-				120,385
Total assets			-				688,649				-				688,649
Liabilities carried at fair value
Warrants**			-				-				-				-
Liabilities carried at amortized cost
Borrowings			-				358,550				-				358,580
Other liabilities			-				308,702				-				308,702
Total Liabilities			-				667,282				-				667,282


		March 31, 2023
		Level 1				Level 2				Level 3				Total
Assets for which fair value is disclosed
Term deposits			-				587,375				-				587,375
Other financial assets			-				122,312				-				122,312
Total assets			-				709,687				-				709,687

Liabilities carried at fair value
Warrants**			-				-				-				-
Liabilities carried at amortized cost
Borrowings			-				2,396,493				-				2,396,493
Other liabilities			-				353,155				-				353,155
Total Liabilities			-				2,749,648				-				2,749,648

Schedule of valuation techniques and significant unobservable inputs

The following tables show the valuation techniques used in measuring fair values at March 31, 2022 and March 31, 2023 as well as the significant unobservable inputs used.

Type		Valuation technique		Significant unobservable inputs			Inter-relationship between significant unobservable inputs and fair value measurement
A. Financial Instruments measured at fair value:
Warrants		Black- Scholes model: The valuation model considers the share price on measurement date, expected term of the instrument, risk free rate (based on government bonds), expected volatility and expected dividend rate.		Expected term : 0.16 years (PY: 0.66 years) Risk free rate : 4.72% (PY 1.11%)			The estimated fair value would increase (decrease) if : • the expected term were higher (lower) • the risk free rate were higher (lower)

Quoted Warrants		Fair market value		-			-

B. Financial Instruments for which fair value is disclosed:

Borrowings		Discounted cash flows		Prevailing interest rate in market, future payouts.			-

Term deposits		Discounted cash flows		Prevailing interest rate to discount future cash flows			-

Other financial assets		Discounted cash flows		Prevailing interest rate to discount future cash flows			-

Other liabilities		Discounted cash flows		Prevailing interest rate to discount future cash flows			-

Schedule of reconciliation of fair value measurements categorized within level 1 and level 3 of the fair value hierarchy

Below is reconciliation of fair value measurements categorized within level 1 & level 3 of the fair value hierarchy

		April 1, 2021				Charge to profit or loss				Effects of movements in foreign exchange rates				March 31, 2022				Charge to profit or loss				Effects of movements in foreign exchange rates				March 31, 2023
Macquarie Corporate Holdings Pty Limited - Ordinary Warrants ( refer note 36)			436				(444	)			8				-				-				-				-
Quoted Warrants*			31,955				(32,312	)			357				-				-				-				-
Total			32,391				(32,756	)			365				-				-				-				-

*

On December 16, 2021, at 5:00 p.m., New York time, outstanding warrants (the “Warrants”) to purchase an aggregate of 17,337,500 Ordinary Shares expired.